Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Trends Endocrinol Metab. 2017 Oct 30;28(12):879–892. doi: 10.1016/j.tem.2017.10.004

Figure 1. Protein S-Nitrosylation in NO Signaling under Neurodegenerative Conditions.

Figure 1

Upon activation by its dual agonists, glutamate and glycine (or D-serine), NMDA receptors (NMDARs) allow entry of Ca2+ into the cytosol of the postsynaptic cell. While synaptic NMDARs mediate synaptic plasticity and neuroprotection, hyperactivation of extrasynaptic NMDARs (eNMDARs) enhances neurotoxicity [94]. Under neurodegenerative conditions, increased Ca2+ influx due predominantly to eNMDAR overactivation stimulates excessive NO production from nNOS. Additionally, NO derived from iNOS in astrocytes augments nitrosative stress. Subsequently, the covalent addition of NO-related species to a reactive cysteine sulfhydryl (or thiolate) group in a target protein leads to the formation of S-nitrosylated (SNO) proteins. For example, pathologically high levels of NO can trigger aberrant S-nitrosylation of mitochondrial proteins, resulting in dysfunction in mitochondrial metabolism and dynamics. NO can also react with superoxide (O2) to yield peroxynitrite (ONOO), leading to tyrosine nitration. In contrast, under physiological conditions, synaptic NMDAR activity maintains relatively low levels of NO production, activating soluble guanylyl cyclase (sGC)/cGMP pathways and neuroprotective protein S-nitrosylation-mediated pathways.